We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$362M
Cap. Flow
-$348M
Cap. Flow %
-25.31%
Top 10 Hldgs %
62.01%
Holding
142
New
43
Increased
15
Reduced
9
Closed
60
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.3 years

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$53.1M
2
KSU
Kansas City Southern
KSU
+$31.9M
3
PF
Pinnacle Foods, Inc.
PF
+$27.7M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$5.3M
5
PCRX icon
Pacira BioSciences
PCRX
+$3.43M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$12.3M
2
INSM icon
Insmed
INSM
+$7.51M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$6.36M
4
DYNC icon
Vistra Energy Corp.
DYNC
+$5.07M
5
NXH icon
Neighborhood Intelligence Inc
NXH
+$3.25M

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.94%
2 Technology 3.93%
3 Industrials 2.49%
4 Consumer Staples 2.13%
5 Healthcare 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
INSM icon
76
CALL
Insmed
INSM
$21.7B
– –
-213,000
Closed -$6.64M –
INSM icon
77
Insmed
INSM
$21.7B
– –
-240,600
Closed -$7.51M –
INSM icon
78
PUT
Insmed
INSM
$21.7B
– –
-376,700
Closed -$11.8M –
MNOV icon
79
PUT
MediciNova
MNOV
$71.4M
– –
-43,800
Closed -$279K –
NBIX icon
80
Neurocrine Biosciences
NBIX
$13.9B
– –
-103,800
Closed -$6.36M –
NBR icon
81
Nabors Industries
NBR
$1.16B
– –
-3,178
Closed -$1.01M –
NBR icon
82
PUT
Nabors Industries
NBR
$1.16B
– –
-2,000
Closed -$807K –
PTCT icon
83
PTC Therapeutics
PTCT
$5.09B
– –
-612,543
Closed -$12.3M –
PTCT icon
84
PUT
PTC Therapeutics
PTCT
$5.09B
– –
-1,735,300
Closed -$34.7M –
RWM icon
85
ProShares Short Russell2000
RWM
$143M
– –
-6,000
Closed -$262K –
T icon
86
PUT
AT&T
T
$161B
– –
-13,240
Closed -$391K –
TEVA icon
87
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
– –
-83,900
Closed -$1.26M –
TEVA icon
88
PUT
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
– –
-142,300
Closed -$2.5M –
ARAV
89
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-94,550
Closed -$1.37M –
SIOX
90
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-184,400
Closed -$10.1M –
DISCK
91
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
– –
-11,000
Closed -$223K –
AKRX
92
DELISTED
Akorn Inc
AKRX
– –
-10,000
Closed -$332K –
CYOU
93
DELISTED
Changyou.com Limited American Depositary Share
CYOU
– –
-7,278
Closed -$288K –
DYNC icon
94
DELISTED
Vistra Energy Corp.
DYNC
– –
-75,000
Closed -$5.07M –
SPA
95
DELISTED
Sparton
SPA
– –
-16,554
Closed -$384K –
OA
96
DELISTED
Orbital ATK, Inc.
OA
– –
-2,000
Closed -$266K –
YUME
97
DELISTED
YuMe, Inc.
YUME
– –
-10,000
Closed -$46K –
GLBL icon
98
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
– –
-20,795
Closed -$99K –
RT
99
DELISTED
Ruby Tuesday Georgia
RT
– –
-10,000
Closed -$21K –
CBF
100
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
– –
-14,000
Closed -$575K –
2 3
4
5 6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return

DLD Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, DLD Asset Management held 142 positions worth $1.38B, up 36% from $1.02B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

DLD Asset Management withdrew a net $348M in Q4 2017, closing 60 positions and reducing 9 holdings. Its most notable exit was PTC Therapeutics, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.

Against the trend, DLD Asset Management opened a new position in Cognizant worth $51.6M.

  • DLD Asset Management's largest Q4 2017 buy was Cognizant: 726,740 shares worth $51.6M.
  • DLD Asset Management added most to Otonomy, Inc. in Q4 2017, an estimated $1.16M increase.
  • DLD Asset Management's biggest Q4 2017 reduction was Lipocine, cutting an estimated $1.03M.
  • DLD Asset Management fully exited PTC Therapeutics in Q4 2017, selling an estimated $12.3M.
  • DLD Asset Management's ten largest holdings make up 62% of its $1.38B portfolio in Q4 2017.
  • DLD Asset Management opened 43 new positions and closed 60 in Q4 2017.
  • DLD Asset Management's portfolio value rose 36% quarter-over-quarter to $1.38B.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.